Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50%: A population‐based nested case–control study

Overview of attention for article published in Journal of Internal Medicine, July 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

news: 3 news outlets
twitter: 5 X users

facebook: 1 Facebook page

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 21,278 followers.

RT @WileyOnc_Hem: According to new research, dual long-acting bronchodilator therapy, rather than long-acting muscarinic antagonist mono-th…

RT @JInternMed: New original article from researchers at @Otago and @AucklandUni! Dual versus single long-acting bronchodilator use could r…

New original article from researchers at @Otago and @AucklandUni! Dual versus single long-acting bronchodilator use could raise acute coronary syndrome risk by over 50%: A population-based nested case–control study #COPD #acutecoronarysyndrome https://t…

RT @WileyOnc_Hem: According to new research, dual long-acting bronchodilator therapy, rather than long-acting muscarinic antagonist mono-th…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.